New Strategies for Growing 3D Tissues (R21)
The summary for the New Strategies for Growing 3D Tissues (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
New Strategies for Growing 3D Tissues (R21): Purpose. This FOA issued by the National Heart, Lung, and Blood Institute (NHLBI), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health, solicits Research Project Grant (R21) applications from institutions/organizations that propose to improve our understanding of how human cells respond to their environment and to develop accurate assays and methods to understand how organogenesis may instruct the creation of functional 3D engineered cellular aggregates. This program will require collaborations of scientists from 2 or more disciplines such as developmental biology, computational science and systems biology, cell biology, tissue engineering, chemistry, physics, or organ physiology. Use of the multiple PI mechanism is strongly encouraged. Multidisciplinary investigations are needed to demonstrate reproducible recapitulation in the laboratory for events such as differentiation, proliferation, and senescence for tissue repair and regeneration. Repairing, replacing, or regenerating tissue will occur by translating fundamental knowledge from biology into engineering systems that support tissue formation, either in vitro or in vivo. Mechanism of Support. This FOA will utilize the R21 award mechanism and runs in parallel with a FOA of identical scientific scope, RFA- HL-11-025, that encourages applications under the R01 mechanism (add URL). Funds Available and Anticipated Number of Awards. The NHLBI intends to commit $1,065,625 total costs in FY2011 to fund up to 5 awards, with a total cost commitment of $2,131,250 over the 2-year period. The NIAMS intends to commit $450,000 total costs in FY2011 to fund up to 2 awards, with a total cost commitment of $900,000 over the 2-year period. The NIBIB intends to commit $500,000 total costs in FY2011 for this and its companion announcement (RFA-HL-11-025), with a total commitment of $1,000,000 over the two year period of this announcement. NIBIB intends to fund up to 2 R21s or 1 R01 under this funding arrangement.
|Federal Grant Title:||New Strategies for Growing 3D Tissues (R21)|
|Federal Agency Name:||National Institutes of Health|
|Type of Opportunity:||Discretionary|
|Funding Opportunity Number:||RFA-HL-11-026|
|Type of Funding:||Grant|
|CFDA Descriptions:||Discovery and Applied Research for Technological Innovations to Improve Human Health|
|Current Application Deadline:||Sep 01, 2010|
|Original Application Deadline:||Sep 01, 2010|
|Posted Date:||Jun 24, 2010|
|Creation Date:||Jun 24, 2010|
|Archive Date:||Oct 02, 2010|
|Total Program Funding:|
|Maximum Federal Grant Award:|
|Minimum Federal Grant Award:|
|Expected Number of Awards:|
|Cost Sharing or Matching:||No|
- Applicants Eligible for this Grant
- State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
- Similar Government Grants
- • Enhancing Science, Technology, EnginEering, and Math Educational Diversity (ESTEEMED) Rese...
- • National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Op...
- • NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional...
- • Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Tria...
- • Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed)
- • Exploratory Grants (P20) for NIBIB Quantum Projects
- • Nibib Research Supplements to Promote Clinical Resident Research Experiences
- • Innovation in Molecular Imaging Probes
- More Grants from the National Institutes of Health
- • Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
- • Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
- • New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...